ONCOLOGY: New Drug RAD001 Plus Letrozole In Neoadjuvant Therapy For Breast Cancer

Audio Journal of Oncology, December 15th, 2007 Reporting from: San Antonio Breast Cancer Symposium, 13-16 December, 2007 New Drug RAD001 Plus Letrozole In Neoadjuvant Therapy For Breast Cancer JOSE BASELGA, Vall d’Hebron Hospital, Barcelona REFERENCE: ABSTRACT 2066 RAD001, a drug targeted at the mTor pathway, has been combined with letrozole in a randomised phase II trial in breast cancer. The investigators saw more responses in the experimental arm, and so Derek Thorne got the details from Jose Baselga of Vall d’Hebron Hospital in Barcelona.

You can listen to ONCOLOGY: New Drug RAD001 Plus Letrozole In Neoadjuvant Therapy For Breast Cancer online on Radio and Podcast. Open the player on this page to stream the available audio.

ONCOLOGY: New Drug RAD001 Plus Letrozole In Neoadjuvant Therapy For Breast Cancer is an episode from Audio Medica News - Medical News Interviews by Audio Medica.

This episode is 00:03:02 long.

This episode was published on Dec 15, 2007.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Audio Medica News - Medical News Interviews when more episodes are available from the podcast feed.